Physician profile
Philip Ente
NPI 1366474819
$1,309.88
in general payments reported to CMS, 2019-2025
14 companies · $304 in 2025
The $304 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $382 · 2022: $96.91 · 2023: $408 · 2024: $119 · 2025: $304.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $481 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $200 · Consulting Fee: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $481.07 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $200.00 |
| Consulting Fee | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $300.00 | 2021-2023 | Tysabri |
| Biohaven Pharmaceuticals, INC. | $231.90 | 2021 | |
| Genzyme Corporation | $200.00 | 2023 | |
| Abbvie INC. | $147.24 | 2025 | |
| Ucb, INC. | $122.79 | 2025 | Fintepla |
| Novartis Pharmaceuticals Corporation | $100.82 | 2024 | |
| Sk Life Science, INC. | $84.75 | 2022 | |
| Lundbeck LLC | $25.00 | 2023 | Vyepti |
| Kyowa Kirin, INC. | $19.97 | 2023 | Nourianz |
| Janssen Biotech, INC. | $19.74 | 2025 | |
| Pfizer INC. | $18.46 | 2024 | |
| Bsn Medical INC | $14.21 | 2025 | |
| Coloplast Corp | $12.84 | 2023 | Altis |
| Impel Pharmaceuticals INC. | $12.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Ente listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.